<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">15784165</PMID>
      <DateCompleted>
        <Year>2005</Year>
        <Month>04</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1582-1838</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>9</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2005</Year>
              <Season>Jan-Mar</Season>
            </PubDate>
          </JournalIssue>
          <Title>Journal of cellular and molecular medicine</Title>
          <ISOAbbreviation>J Cell Mol Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The activation of Akt/PKB signaling pathway and cell survival.</ArticleTitle>
        <Pagination>
          <StartPage>59</StartPage>
          <EndPage>71</EndPage>
          <MedlinePgn>59-71</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Akt/PKB is a serine/threonine protein kinase that functions as a critical regulator of cell survival and proliferation. Akt/PKB family comprises three highly homologous members known as PKBalpha/Akt1, PKBbeta/Akt2 and PKBgamma/Akt3 in mammalian cells. Similar to many other protein kinases, Akt/PKB contains a conserved domain structure including a specific PH domain, a central kinase domain and a carboxyl-terminal regulatory domain that mediates the interaction between signaling molecules. Akt/PKB plays important roles in the signaling pathways in response to growth factors and other extracellular stimuli to regulate several cellular functions including nutrient metabolism, cell growth, apoptosis and survival. This review surveys recent developments in understanding the molecular mechanisms of Akt/PKB activation and its roles in cell survival in normal and cancer cells.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Song</LastName>
            <ForeName>Gang</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>The Key Laboratory of the Ministry of Education for Cell Biology and Tumor Cell Engineering, School of Life Sciences, Xiamen University, Xiamen 361005, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ouyang</LastName>
            <ForeName>Gaoliang</ForeName>
            <Initials>G</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bao</LastName>
            <ForeName>Shideng</ForeName>
            <Initials>S</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Cell Mol Med</MedlineTA>
        <NlmUniqueID>101083777</NlmUniqueID>
        <ISSNLinking>1582-1838</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="C494918">AKT1 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="C494921">AKT2 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2005</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2005</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2005</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">15784165</ArticleId>
        <ArticleId IdType="pmc">PMC6741304</ArticleId>
        <ArticleId IdType="doi">10.1111/j.1582-4934.2005.tb00337.x</ArticleId>
        <ArticleId IdType="pii">009.001.07</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Nicholson K.M., 
Anderson N.G., The Akt/PKB signalling pathway in human malignancy, Cell signal, 14: 381–395, 2002.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11882383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hajduch E, 
Litherland G.J., 
Hundal H.S., Protein kinase B (Akt/PKB)‐a key regulator of glucose transport?, FEBS Lett., 492: 199–203, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11257494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Coffer P.J., 
Woodgett J.R., Molecular cloning and characterization of a novel putative protein‐serine kinase related to the cAMP dependent and protein kinase C families, Eur. J. Biochem., 201: 475–481, 1991.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1718748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jones P.F., 
Jakubowicz T., 
Pitossi F.J., 
Maurer F., 
Hemmings B.A., Molecular cloning and identification of a serine/threonine protein kinase of the second‐messenger subfamily, Proc. Natl. Acad. Sci. USA., 88: 4171–4175, 1991.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC51620</ArticleId>
            <ArticleId IdType="pubmed">1851997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bellacosa A., 
Testa J.R., 
Staal S.P., 
Tsichlis P.N., A retroviral oncogene, akt, encoding a serine‐threonine kinase containing an SH2‐like region, Science, 254: 274–277, 1991.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1833819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jones P.F., 
Jakubowicz T., 
Hemmings B.A., Molecular cloning of a second form of rac protein kinase, Cell Regul., 2: 1001–1009, 1991.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC361900</ArticleId>
            <ArticleId IdType="pubmed">1801921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cheng J.Q., 
Godwin A.K., 
Bellacosa A., 
Taguchi T., 
Franke T.F., 
Hamilton T.C., 
Tsichlis P.N., 
Testa J.R., AKT2, a putative oncogene encoding a member of a subfamily of protein‐serine/threonine kinases, is amplified in human ovarian carcinomas, Proc. Natl. Acad. Sci. USA., 89: 9267–9271, 1992.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC50107</ArticleId>
            <ArticleId IdType="pubmed">1409633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brodbeck D., 
Cron P., 
Hemmings B.A., A human protein kinase B with regulatory phosphorylation sites in the activation loop and in the C‐terminal hydrophobic domain, J. Biol. Chem., 274: 9133–9136, 1999.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10092583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brazil D.P., 
Hemmings B.A., Ten years of protein kinase B signalling: a hard Akt to follow, Trends Biochem. Sci., 26: 657–664, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11701324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tyers M., 
Rachubinski R.A., 
Stewart M.I., 
Varrichio A.M., 
Shorr R.G., 
Haslam R.J., 
Harley C.B., Molecular cloning and expression of the major protein kinase C substrate of platelets, Nature, 333: 470–473, 1998.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2897630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lietzke S.E., 
Bose S., 
Cronin T., 
Klarlund J., 
Chawla A., 
Czech M.P., 
Lambright D.G., Structural basis of 3‐phosphoinositide recognition by pleckstrin homology domains, Mol Cell, 6: 385–394, 2000.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10983985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ferguson K.M., 
Kavran J.M., 
Sankaran V.G., 
Fournier E., 
Isakoff S.J., 
Skolnik E.Y., 
Lemmon M.A., Structural basis for discrimination of 3‐phosphoinositides by pleckstrin homology domains, Mol. Cell, 6: 373–384, 2000.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10983984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
James S.R., 
Downes C.P., 
Gigg R., 
Grove S.J., 
Holmes A.B., 
Alessi D.R., Specific binding of the Akt‐1 protein kinase to phosphatidylinositol 3,4,5‐trisphosphate without subsequent activation, Biochem. J., 315: 709–713, 1996.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1217264</ArticleId>
            <ArticleId IdType="pubmed">8645147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Frech M., 
Andjelkovic M., 
Ingley E., 
Reddy K.K., 
Falck J.R., 
Hemmings B.A., High affinity binding of inositol phosphates and phosphoinositides to the Pleckstrin homology domain of RAC protein kinase B and their influence on kinase activity, J. Biol. Chem., 272: 8474–8481, 1997.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9079675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Thomas C.C., 
Deak M., 
Alessi D.R., 
Van Aalten D.M., High‐resolution structure of the pleckstrin homology domain of Akt/PKB bound to phosphatidylinositol (3,4,5)‐ trisphosphate, Curr. Biol., 12: 1256–1262, 2002.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12176338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Peterson R.T., 
Schreiber S.L., Kinase phosphorylation: keeping it all in the family, Curr. Biol., 9: R521–524, 1999.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10421571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Alessi D.R., 
Andjelkovic M., 
Caudwell B., 
Cron P., 
Morrice N., 
Cohen P., 
Hemmings B.A., Mechanism of activation of protein kinase B by insulin and IGF‐1, EMBO. J., 15: 6541–6551, 1996.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC452479</ArticleId>
            <ArticleId IdType="pubmed">8978681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Andjelkovic M., 
Alessi D.R., 
Meier R., 
Fernandez A., 
Lamb N.J., 
Frech M., 
Cron P., 
Cohen P., 
Lucocq J.M., 
Hemmings B.A., Role of translocation in the activation and function of protein kinase B, J. Biol. Chem., 272: 31515–31524, 1997.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9395488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brodbeck D., 
Hill M.M., 
Hemmings B.A., Two splice variants of protein kinase B g have different regulatory capacity depending on the presence or absence of the regulatory phosphorylation site serine 472 in the carboxyl‐terminal hydrophobic domain, J. Biol. Chem., 276: 29550–29558, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11387345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Konishi H., 
Kuroda S., 
Tanaka M., 
Matsuzaki H., 
Ono Y., 
Kameyama K., 
Haga T., 
Kikkawa U., Molecular cloning and characterization of a new member of the RAC protein kinase family: association of the pleckstrin homology domain of three types of RAC protein kinase with protein kinase C subspecies and beta gamma subunits of G proteins, Biochem. Biophys. Res. Commun., 216: 526–534, 1995.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7488143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wymann M.P., 
Zvelebil M., 
Laffargue M., Phosphoinositide 3‐kinase signaling‐which way to target?, Trends Pharmacol. Sci., 24: 366–376, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12871670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Simpson L., 
Parsons R., PTEN: life as a tumor suppressor, Exp. Cell. Res, 264: 29–41, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11237521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lemmon M.A., 
Ferguson K.M., Signal‐dependent membrane targeting by pleckstrin homology (PH) domains, Biochem. J., 350: 1–18, 2000.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1221219</ArticleId>
            <ArticleId IdType="pubmed">10926821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Andjelkovic M., 
Alessi D.R., 
Meier R., 
Fernandez A., 
Lamb N.J., 
Frech M., 
Cron P., 
Cohen P., 
Lucocq J.M., 
Hemmings B.A., Role of translocation in the activation and function of protein kinase B, J. Biol. Chem., 272: 31515–31524, 1997.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9395488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Stephens L., 
Anderson K., 
Stokoe D., 
Erdjument‐Bromage H., 
Painter G.F., 
Holmes A.B., 
Gaffney P.R., 
Reese C.B., 
McCormick F., 
Tempst P., 
Coadwell J., 
Hawkins P.T., Protein kinase B kinases that mediate phosphatidylinositol 3,4,5‐trisphosphate‐dependent activation of protein kinase B, Science, 279: 710–714, 1998.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9445477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Toker A., 
Newton A.C., Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK‐2 site, J. Biol. Chem., 275: 8271–8274, 2000.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10722653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Persad S., 
Attwell S, 
Gray V., 
Mawji N., 
Deng J.T., 
Leung D., 
Yan J., 
Sanghera J., 
Walsh M.P., 
Dedhar S., Regulation of Akt/PKB‐serine 473 phosphorylation by integrin‐linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343, J. Biol. Chem., 276: 27462–27469, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11313365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Conus N.M., 
Hannan K.M., 
Cristiano B.E., 
Hemmings B.A., 
Pearson R.B., Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase, J. Biol. Chem., 277: 38021–38028, 2002.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12149249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jiang T., 
Qiu Y., Interaction between Src and a C‐terminal proline‐rich motif of Akt is required for Akt activation, J. Biol. Chem., 278: 15789–15793, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12600984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mora A., 
Komander D., 
Van Aalten D.M., 
Alessi D.R., PDK1, the master regulator of AGC kinase signal transduction, Semin Cell Dev. Biol., 15: 161–170, 2004.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15209375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Biondi R.M., 
Cheung P.C., 
Casamayor A., 
Deak M., 
Currie R.A., 
Alessi D.R., Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C‐terminal residues of PKA, EMBO. J., 19: 979–988, 2000.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC305637</ArticleId>
            <ArticleId IdType="pubmed">10698939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Biondi R.M., 
Kieloch A., 
Currie R.A., 
Deak M., 
Alessi D.R., The PIF‐binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB, EMBO. J., 20: 4380–4390, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC125563</ArticleId>
            <ArticleId IdType="pubmed">11500365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Collins B.J., 
Deak M., 
Arthur J.S., 
Armit L.J., 
Alessi D.R., In vivo role of the PIF‐binding docking site of PDK1 defined by knock‐in mutation, EMBO. J., 22: 4202–4211, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC175797</ArticleId>
            <ArticleId IdType="pubmed">12912918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Anderson K.E., 
Coadwell J., 
Stephens L.R., 
Hawkins P.T., Translocation of PDK‐1 to the plasma membrane is important in allowing PDK‐1 to activate protein kinase B, Curr. Biol., 8: 684–691, 1998.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9637919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Balendran A., 
Casamayor A., 
Deak M., 
Paterson A., 
Gaffney P., 
Currie R., 
Downes C.P., 
Alessi D.R., PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2, Curr. Biol., 9: 393–404, 1999.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10226025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Williams M.R., 
Arthur J.S., 
Balendran A., 
van der Kaay J., 
Poli V., 
Cohen P., 
Alessi D.R., The role of 3‐phosphoinositide‐dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells, Curr. Biol., 10: 439–448, 2000.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10801415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hill M.M., 
Andjelkovic M., 
Brazil D.P., 
Ferrari S., 
Fabbro D., 
Hemmings B.A., Insulin‐stimulated protein kinase B phosphorylation on Ser‐473 is independent of its activity and occurs through a staurosporine‐insensitive kinase, J. Biol. Chem., 276: 25643–25646, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11373274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Toker A., 
Newton A.C., Akt/Protein kinase B is regulated by autophosphorylation at the hypothetical PDK‐2 site, J. Biol. Chem., 275: 8271–8274, 2000.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10722653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Laine J., 
Kunstle G., 
Obata T., 
Sha M., 
Noguchi M., The protooncogene TCL1 is an Akt kinase coactivator, Mol. Cell, 6: 395–407, 2000.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10983986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hill M.M., 
Andjelkovic M., 
Brazil D.P., 
Ferrari S., 
Fabbro D., 
Hemmings B.A., Insulin‐stimulated protein kinase B phosphorylation on Ser‐473 is independent of its activity and occurs through a staurosporine‐insensitive kinase, J. Biol. Chem., 276: 25643–25646, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11373274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Delcommenne M., 
Tan C., 
Gray V., 
Rue L., 
Woodgett J., 
Dedhar S., Phosphoinositide‐3‐OH kinase‐dependent regulation of glycogen synthase kinase 3 and Akt/PKB by the integrin‐linked kinase, Proc. Natl. Acad. Sci. USA., 95: 11211–11216, 1998.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC21621</ArticleId>
            <ArticleId IdType="pubmed">9736715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lynch D.K., 
Ellis C.A., 
Edwards P.A., 
Hiles I.D., Integrin‐linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism, Oncogene, 18: 8024–8032, 1999.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10637513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Persad S., 
Attwell S., 
Gray V., 
Mawji N., 
Deng J.T., 
Leung D., 
Yan J., 
Sanghera J., 
Walsh M.P., 
Dedhar S., Regulation of Akt/PKB‐serine 473 phosphorylation by integrin‐linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343, J. Biol. Chem., 276: 27462–27469, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11313365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen R., 
Kim O., 
Yang J., 
Sato K., 
Eisenmann K.M., 
McCarthy J., 
Chen H., 
Qiu Y., Regulation of Akt/PKB activation by tyrosine phosphorylation, J. Biol. Chem., 276: 31858–31862, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11445557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sable C.L., 
Filippa N., 
Hemmings B., 
Van Obberghen E., cAMP stimulates protein kinase B in a Wortmannininsensitive manner, FEBS. Lett., 409: 253–257, 1997.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9202156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Filippa N., 
Sable C.L., 
Filloux C., 
Hemmings B.A., 
Van Obberghen E., Mechanism of protein kinase B activation by cyclic AMP‐dependent protein kinase, Mol. Cell Biol., 19: 4989–5000, 1999.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC84322</ArticleId>
            <ArticleId IdType="pubmed">10373549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Perez‐Garcia M.J., 
Cena V., 
De Pablo Y., 
Llovera M., 
Comella J.X., 
Soler R.M., Glial cell line‐derived neurotrophic factor increases intracellular calcium concentration. Role of calcium/calmodulin in the activation of the phosphatidylinositol 3‐kinase pathway, J. Biol. Chem., 279: 6132–6142, 2004.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14630929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Konishi H., 
Matsuzaki H., 
Tanaka M., 
Takemura Y., 
Kuroda S., 
Ono Y., 
Kikkawa U., Activation of protein kinase B (Akt/RAC‐protein kinase) by cellular stress and its association with heat shock protein Hsp27, FEBS. Lett., 410: 493–498, 1997.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9237690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Moule S.K., 
Welsh G.I., 
Edgell N.J., 
Foulstone E.J., 
Proud C.G., 
Denton R.M., Regulation of protein kinase B and glycogen synthase kinase‐3 by insulin and betaadrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin‐sensitive and ‐insensitive mechanisms, J. Biol. Chem., 272: 7713–7719, 1997.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9065430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brazil D.P., 
Park J., 
Hemmings B.A., PKB binding proteins: Getting in on the Akt, Cell, 111: 293–303, 2002.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12419241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Maira S.M., 
Galetic I., 
Brazil D.P., 
Kaech S., 
Ingley E., 
Thelen M., 
Hemmings B.A., Carboxyl‐terminal modulator protein (CTMP), a negative regulator of Akt/PKB and v‐Akt at the plasma membrane, Science, 294: 374–380, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11598301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Du K., 
Herzig S., 
Kulkarni R.N., 
Montminy M., TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver, Science, 300: 1574–1577, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12791994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Paramio J.M., 
Segrelles C., 
Ruiz S., 
Jorcano J.L., Inhibition of protein kinase B (PKB) and PKC‐mediates keratin K10‐induced cell cycle arrest, Mol. Cell Biol., 21: 7449–7459, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC99917</ArticleId>
            <ArticleId IdType="pubmed">11585925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Konishi H., 
Matsuzaki H., 
Tanaka M., Activation of protein kinase B (Akt/RAC‐protein kinase) by cellular stress and its association with heat shock protein Hsp27, FEBS. Lett., 410: 493–498, 1997.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9237690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rane M.J., 
Pan Y., 
Singh S., 
Powell D.W., 
Wu R., 
Cummins T., 
Chen Q., 
McLeish K.R., 
Klein J.B., Heat shock protein 27 controls apoptosis by regulating Akt activation, J. Biol. Chem., 278: 27828–27835, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12740362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Solit D.B., 
Basso A.D., 
Olshen A.B., 
Scher H.I., 
Rosen N., Inhibition of heat shock protein 90 function down‐regulates Akt kinase and sensitizes tumors to Taxol, Cancer Res., 63: 2139–2144, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12727831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Han D.C., 
Shen T.L., 
Guan J.L., The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions, Oncogene, 20: 6315–6321, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11607834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jahn T., 
Seipel P., 
Urschel S., 
Peschel C., 
Duyster J., Role for the adaptor protein Grb 10 in the activation of Akt, Mol. Cell Biol., 22: 979–991, 2002.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC134632</ArticleId>
            <ArticleId IdType="pubmed">11809791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pekarsky Y., 
Koval A., 
Hallas C., 
Bichi R., 
Tresini M., 
Malstrom S., 
Russo G., 
Tsichlis P., 
Croce C.M., Tcll enhances Akt kinase activity and mediates its nuclear translocation, Proc. Natl. Acad. Sci. USA., 97: 3028–3303, 2000.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC16186</ArticleId>
            <ArticleId IdType="pubmed">10716693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Auguin D., 
Barthe P., 
Royer C., 
Stern M.H., 
Noguchi M., 
Arold S.T., 
Roumestand C., Structural basis for the coactivation of protein kinase B by T‐cell leukemia‐1 (TCL1) family proto‐oncoproteins, J. Biol. Chem., 279: 35890–35902, 2004.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15169787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Remy I., 
Michnick S.W., Regulation of apoptosis by the Ft 1 protein, a new modulator of Akt/PKB, Mol. Cell Biol., 24: 1493–1504, 2004.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC344167</ArticleId>
            <ArticleId IdType="pubmed">14749367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cenni V., 
Sirri A., 
Riccio M., 
Lattanzi G., 
Santi S., 
De Pol A., 
Maraldi N.M., 
Marmiroli S., Targeting of the Akt/PKB kinase to the actin skeleton, Cell Mol. Life Sci., 60: 2710–27120, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14685694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sinha D., 
Bannergee S., 
Schwartz J.H., 
Lieberthal W., 
Levine J.S., Inhibition of ligand‐independent ERK1/2 activity in kidney proximal tubular cells deprived of soluble survival factors upregulates Akt and prevents apoptosis, J. Biol. Chem., 279: 10962–10972, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14701865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kim A.H., 
Yano H., 
Cho H., 
Meyer D., 
Monks B., 
Margolis B., 
Birnbaum M.J., 
Chao M.V., Akt 1 regulates a JNK scaffold during excitotoxic apoptosis, Neuron, 35: 697–709, 2002.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12194869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
van den Heuvel A.P., 
De Vries‐Smits A.M., 
Van Weeren P.C., 
Dijkers P.F., 
De Bruyn K.M., 
Riedl J.A., 
Burgering B.M., Binding of protein kinase B to the plakin family member periplakin, J. Cell Sci., 115: 3957–3966, 2002.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12244133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Figueroa C., 
Tarras S., 
Taylor J., 
Vojtek A.B., Akt2 negatively regulates assembly of the POSH‐MLK‐JNK signaling complex, J. Biol. Chem., 278: 47922–47927, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14504284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yao R., 
Cooper G.M., Requirement for phosphatidylinositol‐3 kinase in the prevention of apoptosis by nerve growth factor, Science, 267: 2003–2006, 1995.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7701324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bao S.D., 
Ouyang G.L., 
Bai X.F., 
Huang Z., 
Ma C., 
Liu M., 
Shao R., 
Anderson R.M., 
Rich J.N., 
Wang X.F., Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway, Cancer Cell, 5: 329–339, 2004.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15093540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shi Q, 
Bao SD, 
Maxwell JA, 
Reesel E.D., 
Friedmanl H.F., 
Bigner D.D., 
Wang X. F., 
Richl J.N., Secreted Protein Acidic, Rich in Cysteine (SPARC) Mediates Cellular Survival of Gliomas through AKT Activation, J. Biol. Chem., 279: 52200–52209, 2004.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15469933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gupta D., 
Syed N.A., 
Roesler W.J., 
Khandelwal R.L., Effect of overexpression and nuclear translocation of constitutively active PKB‐alpha on cellular survival and proliferation in HepG2 cells, J. Cell Biochem., 93: 513, 2004.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15372623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wendel H.G., 
De Stanchina E., 
Fridman J.S., 
Malina A., 
Ray S., 
Kogan S., 
Cordon‐Cardo C., 
Pelletier J., 
Lowe S.W., Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy, Nature, 428: 332–337, 2004.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15029198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Thornberry N.A., 
Lazebnik Y., Caspases: Enemies within, Science, 281: 312–316, 1998.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9721091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Adams J.M., 
Cory S., The Bcl‐2 protein family: Arbiters of cell survival, Science, 281: 1322–1326, 1998.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9735050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Del Peso L., 
Gonzalez‐Garcia M., 
Page C., 
Herrera R., 
Nunez G., Interleukin‐3‐induced phosphorylation of BAD through the protein kinase Akt, Science, 278: 687–689, 1997.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9381178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Datta S.R., 
Dudek H., 
Tao X., 
Masters S., 
Fu H., 
Gotoh Y., 
Greenberg M.E., Akt phosphorylation of BAD couples survival signals to the cell‐intrinsic death machinery, Cell, 91: 231–241, 1997.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9346240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Datta S.R., 
Brunet A., 
Greenberg M.E., Cellular survival: a play in three Akts, Genes Dev., 13: 2905–2927, 1999.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10579998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Donepudi M., 
Grutter M.G., Structure and zymogen activation of caspases, 
Biophys. Chem.
, 145–153, 2002.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12487996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cardone M.H., 
Roy N., 
Stennicke H.R., 
Salvesen G.S., 
Franke T.F., 
Stanbridge E., 
Frisch S., 
Reed J.C., Regulation of cell death protease caspase‐9 by phosphorylation, Science, 282: 1318–1321, 1998.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9812896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fujita E., 
Jinbo A., 
Matuzaki H., 
Konishi H., 
Kikkawa U., 
Momoi T., Akt phosphorylation site found in human caspase‐9 is absent in mouse caspase‐9, Biochem. Biophys. Res. Commun., 264: 550–555, 1999.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10529400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Johnson G.L., 
Lapadat R., Mitogen‐activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases, Science, 298: 1911–1912, 2002.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12471242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kim A.H., 
Khursigara G., 
Sun X., 
Franke T.F., 
Chao M.V., Akt phosphorylates and negatively regulates apoptosis signal‐regulating kinase 1, Mol. Cell Biol., 21: 893–901, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC86680</ArticleId>
            <ArticleId IdType="pubmed">11154276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Barthwal M.K., 
Sathyanarayana P., 
Kundu C.N., 
Rana B., 
Pradeep A., 
Sharma C., 
Woodgett J.R., 
Rana A., Negative regulation of mixed lineage kinase 3 by Akt/PKB leads to cell survival, J. Biol. Chem., 278: 3897–3902, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12458207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Park H.S., 
Kim M.S., 
Huh S.H., 
Park J., 
Chung J., 
Kang S.S., 
Choi E.J., Akt (protein kinase B) negatively regulates SEK 1 by means of protein phosphorylation, J. Biol. Chem., 277: 2573–2578, 2002.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11707464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Paradis S., 
Ruvkun G., Caenorhabditis elegans Akt/PKB transduces insulin receptor‐like signals from AGE‐1 PI3 kinase to the DAF‐16 transcription factor, Genes Dev., 12: 2488–2498, 1998.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC317081</ArticleId>
            <ArticleId IdType="pubmed">9716402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Burgering B.M., 
Medema R.H., Decisions on life and death: FOXO Forkhead transcription factors are in command when Akt/PKB is off duty, J. Leukoc. Biol., 73: 689–701, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12773501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li Q., 
Verma I.M., NF‐KB regulation in the immune system, Nat. Rev. Immunol., 2: 725–734, 2000.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12360211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kane L.P., 
Shapiro V.S., 
Stokoe D., 
Weiss A., Induction of NF‐kappaB by the Akt/PKB kinase, Curr. Biol., 9: 601–604, 1999.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10359702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Barkett M., 
Gilmore T.D., Control of apoptosis by Rel/NF‐KB transcription factors, Oncogene, 18: 6910–6924, 1999.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10602466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lauder A., 
Castellanos A., 
Weston K., c‐Myb transcription is activated by protein kinase B (PKB) following interleukin 2 stimulation of T cells and is required for PKB‐mediated protection from apoptosis, Mol. Cell Biol., 21: 5797–5805, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC87299</ArticleId>
            <ArticleId IdType="pubmed">11486019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shimizu H., 
Hupp T.R., Intrasteric regulation of MDM2, Trends Biochem. Sci., 28: 346–349, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12877998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Oren M., Decision making by p53: life, death and cancer, Cell Death Differ., 10: 431–442, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12719720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mayo L.D., 
Donner D.B., A phosphatidylinositol 3‐kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus, Proc. Natl. Acad. Sci. USA., 98: 11598–11603, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC58775</ArticleId>
            <ArticleId IdType="pubmed">11504915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gottlieb T.M., 
Leal J.F., 
Seger R., 
Taya Y., 
Oren M., Cross‐talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis, Oncogene, 21: 1299–1303, 2002.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11850850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Du K., 
Montminy M., CREB is a regulatory target for the protein kinase Akt/PKB, J. Biol. Chem., 273: 32377–32379, 1998.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9829964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang J.M., 
Chao J.R., 

Chen. W.
, 
FKuo M.L., 
Yen J.J., 
Yang‐Yen H.F., The antiapoptotic gene mcl‐l is up‐regulated by the phsophatidylinositol 3‐kinase/Akt signaling pathway through a transcription factor complex containing CREB, Mol. Cell Biol., 19: 6195–7206, 1999.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC84561</ArticleId>
            <ArticleId IdType="pubmed">10454566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Basu S., 
Totty N.F., 
Irwin M.S., 
Sudol M., 
Downward J., Akt phosphoralates the Yet‐associated protein, YAP, to induce interaction with 14‐3‐3 and attenuatin of p73‐mediated apoptosis, Mol. Cell, 11: 11–23, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12535517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cross D.A., 
Alessi D.R., 
Cohen P., 
Andjelkovich M., Hemmings B.A., Inhibition of glycogen synthase kinase‐3 by insulin mediated by protein kinase B, Nature, 378: 785–789, 1995.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8524413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Doble B.W., 
Woodgett J.R., GSK‐3: tricks of the trade for a multi‐tasking kinase, J. Cell Sci., 116: 1175–1186, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3006448</ArticleId>
            <ArticleId IdType="pubmed">12615961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pap M., 
Cooper G.M., Role of glycogen synthase kinase‐3 in the phosphatidylinsitol 3‐kinase/Akt cell survival pathway, J. Biol. Chem., 273: 19929–19932, 1998.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9685326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rathmell J.C., 
Vander Heiden M.G., 
Harris M.H., 
Frauwirth K.A., 
Thompson C.B., In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability, Mol. Cell, 6: 683–692, 2000.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11030347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Edinger A.L., 
Thompson C.B., Akt maintains cell size and survival by increasing mTOR‐dependent nutrient uptake, Mol. Biol. Cell, 13: 2276–2288, 2002.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC117312</ArticleId>
            <ArticleId IdType="pubmed">12134068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vander Heiden M.G., 
Plas D.R., 
Rathmell J.C., 
Fox C.J., 
Harris M.H., 
Thompson C.B., Growth factors can influence cell growth and survival through effects on glucose metabolism, Mol. Cell Biol., 21: 5899–5912, 2001.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC87309</ArticleId>
            <ArticleId IdType="pubmed">11486029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rathmell J.C., 
Fox C.J., 
Plas D.R., 
Hammerman P.S., 
Cinalli R.M., 
Thompson C.B., Akt‐directed glucose metabolism can prevent Bax conformation change and promote growth factor‐independent survival, Mol. Cell Biol., 23: 7315–7328, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC230333</ArticleId>
            <ArticleId IdType="pubmed">14517300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chun K.H., 
Kosmeder J.W. 2nd, 
Sun S., 
Pezzuto J.M., 
Lotan R., 
Hong W.K., 
Lee H.Y., Effects of deguelin on the phosphatidylinositol 3‐kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells, J. Natl. Cancer Inst., 95: 291–302, 2003.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12591985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lee H.Y., Molecular mechanisms of deguelin‐induced apoptosis in transformed human bronchial epithelial cells, Biochem. Pharmacol., 68: 1119–1124, 2004.
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15313408</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
